Ultragenyx Pharmaceutical
RARE
RARE
170 hedge funds and large institutions have $3.74B invested in Ultragenyx Pharmaceutical in 2019 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 75 increasing their positions, 43 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
8% less capital invested
Capital invested by funds: $4.05B → $3.74B (-$306M)
15% less first-time investments, than exits
New positions opened: 22 | Existing positions closed: 26
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Holders
170
Holding in Top 10
–
Calls
$10.4M
Puts
$9.37M
Top Buyers
| 1 | +$70.5M | |
| 2 | +$17.2M | |
| 3 | +$13.9M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$12.6M |
| 5 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
+$11.4M |
Top Sellers
| 1 | -$31.1M | |
| 2 | -$21.8M | |
| 3 | -$20.9M | |
| 4 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
-$17.2M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$14.4M |